)
Edge6 Feb 2026
SharkNinja: Viral by Design
How SharkNinja built a repeatable growth engine, turning overlooked appliance categories into global brands through consumer insight and iteration.
iBio
iBio (IBIO) investor relations material
iBio Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary10 Feb, 2026
Executive summary
Focused on preclinical development of AI-driven precision antibodies for cardiometabolic and obesity indications, with IBIO-600 and IBIO-610 expected to enter clinical trials in 2026 and 2027, supported by new data and scientific presentations.
Strategic collaborations, notably with AstralBio, have expanded the pipeline and provided exclusive licenses for key assets.
Secured $26 million in PIPE financing, extending cash runway into Q3 FY2028.
The company is actively seeking partners for certain assets and out-licensing opportunities to maximize value and accelerate development.
Financial highlights
Net loss for the quarter ended December 31, 2025 was $9.0 million ($0.09 per share), compared to $4.4 million ($0.48 per share) in the prior year period.
Net loss for the six months ended December 31, 2025 was $14.7 million ($0.19 per share), up from $8.4 million ($0.94 per share) year-over-year.
Total operating expenses for the quarter were $9.4 million, up from $4.6 million in the prior year, driven by increased R&D and a $2.5 million impairment charge.
Cash, cash equivalents, and investments totaled $52.7 million as of December 31, 2025.
R&D expenses increased to $4.3 million from $1.9 million year-over-year, and G&A expenses rose to $5.2 million from $2.7 million, mainly due to impairment of an intangible asset.
Outlook and guidance
IBIO-610 is on track for first human clinical trials in early 2027; IBIO-600 expected to enter Phase 1a trials in the first half of 2026.
Current cash, cash equivalents, and investments, plus $26 million raised in January 2026, are expected to fund operations into Q3 fiscal 2028.
No significant revenue is expected for several years; focus remains on advancing the pipeline and seeking partnerships.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next iBio earnings date
Oppenheimer 36th Annual Healthcare Life Sciences Conference26 Feb, 2026
iBio
Next iBio earnings date
Oppenheimer 36th Annual Healthcare Life Sciences Conference26 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Bio iBionext, Inc., provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company offers development and manufacturing services for pharmaceuticals; laboratory research and diagnostics; protein research, engineering, and discovery; cell culture media products; pathogen detection; and bioproduction, packaging, and validation services. It sources raw materials from commercial suppliers primarily in North America. The company was founded in 1983 and is based in Westlake Village, California.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage